Antithrombin levels and blood thinning response in heart surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at whether a protein called antithrombin can predict how well a blood thinner called heparin will work during heart surgery. Understanding this connection may help doctors better manage blood clotting during your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are having planned heart surgery that uses a heart-lung machine (cardiopulmonary bypass)
- You are able to give informed consent to participate
- Your surgery is scheduled in advance (not an emergency)
- You are not already taking antithrombin supplements before surgery
- You do not have a severe inherited bleeding or clotting disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This study examines how heart-lung machines used during heart surgery affect blood platelets (clotting cells) and the body's inflammatory response. Understanding these changes may help doctors better manage bleeding and inflammation after cardiac surgery.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This study tests a new blood test that measures how well your platelets (clotting cells) work to predict if you might bleed more after heart surgery. The goal is to catch bleeding problems early and help doctors manage them better.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.